Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Summit Therapeutics plc (‘Summit’ or the ’Company’) Summit Highlights Importance of Innovation in Fight Against Antibiotic Resistance During Antibiotics Awareness Week Preclinical Data on New...
-
Summit Therapeutics plc (‘Summit’ or the ’Company’) Appointment of Joint Broker Oxford, UK, and Cambridge, MA, US, 12 November 2018 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader...
-
Summit Therapeutics plc (‘Summit’ or the ’Company’) Summit Therapeutics to Participate in Jefferies 2018 London Healthcare Conference Oxford, UK, and Cambridge, MA, US, 7 November 2018 –...
-
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the...
-
Summit Therapeutics plc (‘Summit’ or the ’Company’) Summit Recognises C. difficile Awareness Month Oxford, UK, and Cambridge, MA, US, 1 November 2018 – Summit Therapeutics plc (NASDAQ:...
-
Summit Therapeutics plc (‘Summit’ or the ’Company’) Exercise of Restricted Stock Units, Director Dealings and Total Voting Rights Oxford, UK, and Cambridge, MA, US, 24 October 2018 – Summit...
-
Summit Therapeutics plc (‘Summit’ or the ’Company’) Award of Share Options Oxford, UK, and Cambridge, MA, US, 22 October 2018 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new...
-
Summit Therapeutics plc (‘Summit’ or the ’Company’) Summit Therapeutics to Participate in Upcoming Investor Events Oxford, UK, and Cambridge, MA, US, 10 October 2018 – Summit Therapeutics...
-
Summit Therapeutics plc (‘Summit’ or the ’Company’) Surrender of Share Options Oxford, UK, and Cambridge, MA, US, 8 October 2018 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in...
-
Summit Therapeutics plc (‘Summit’ or the ’Company’) Summit Highlights Phase 3-Ready Precision Antibiotic Ridinilazole at IDWeek 2018 Ridinilazole in Development to Treat C. difficile Infection and...